Proteome Sciences (LON:PRM) Shares Up 12.4% – Here’s Why

Proteome Sciences plc (LON:PRM)’s share price rose 12.4% on Monday . The company traded as high as GBX 2.08 and last traded at GBX 2.08. Approximately 100,788 shares were traded during mid-day trading, a decline of 86% from the average daily volume of 703,207 shares. The stock had previously closed at GBX 1.85.

Proteome Sciences Stock Performance

The stock has a market cap of £7.30 million, a price-to-earnings ratio of -1.84 and a beta of 0.07. The company has a current ratio of 0.20, a quick ratio of 0.37 and a debt-to-equity ratio of -258.66. The firm has a fifty day simple moving average of GBX 2.45 and a 200-day simple moving average of GBX 2.43.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.